Filing Details
INTEGRA LIFESCIENCES HOLDINGS CORP (NASDAQ:IART) filed a Form 8-K with the Securities and Exchange Commission on October 21, 2026, disclosing a material event.
8k filedNASDAQ:IART
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) Reports Material Event to SEC
INTEGRA LIFESCIENCES HOLDINGS CORP (NASDAQ:IART) filed a Form 8-K with the Securities and Exchange Commission on October 21, 2026, disclosing a material event.
At publication ·
What changed
INTEGRA LIFESCIENCES HOLDINGS CORP (NASDAQ:IART) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Integra LifeSciences filed a Form 8-K on October 21, 2026, disclosing a material event that shareholders should know about.
- The company's stock trades at $11.84 with a market capitalization of $1.1 billion.
- Material events reported in 8-K filings can include leadership changes, acquisitions, asset sales, or guidance changes.
Market Context
INTEGRA LIFESCIENCES HOLDINGS CORP's stock currently trades at $11.84 with a market capitalization of $1.1B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for INTEGRA LIFESCIENCES HOLDINGS CORP's stock.
All SEC filings for INTEGRA LIFESCIENCES HOLDINGS CORP are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View IART Stock Page
Frequently Asked Questions
Where can I read IART's SEC filings?
Browse all filings on our IART SEC filings page.
What types of SEC filings does INTEGRA LIFESCIENCES HOLDINGS CORP file?
Public companies like INTEGRA LIFESCIENCES HOLDINGS CORP file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
